| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| GOSS | Gossamer Bio, Inc. | President & CEO, Director | $15.9M | Oct 1, 2025 | ||
| KURA | Kura Oncology, Inc. | Director | $192K | -$181K | -48.6% | Jun 5, 2025 |
| MRTX | Mirati Therapeutics, Inc. | Director | Jan 23, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|